But if they are going through approval process, then data must be unblocked. The only reason I can think of to keep it quiet is Buyout. The stock is being kept low for a reason. Purely guessing but maybe the buyout is contingent on approval and they have allready negotiated price.
I am a novice on the stock market and the past few months with NWBO has been a lesson on manipulation, phantom shares, and reading graphs (thank you sojourner).
If/when approved, I would think everyone would want this treatment. Buyout would be the logical option, BP has to have crunched some numbers and seen the potential. Merck has some deep pockets right now, plus distribution and PR. As people have stated, the board is getting up there in years and this would be a perfect opportunity to pass the torch. Not to mention quickly getting other trials underway. But as always, just my opinion. I learn something new here every day.
News 
Market Data 
Discover 
